Patent details
LUC00291 Product Name: Pepaxti
Basic Information
- Publication number:
- LUC00291
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP127189496
- Legal Status:
- Inactive
- Application number:
- LUC00291
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1669
- Marketing Authorization Type:
- Marketing Authorization Date:
- 18/08/2022
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 13/12/2022
- First Marketing Authorization date:
- 18/08/2022
- Grant date:
- 12/05/2025
- Activation date:
- Publication date:
- 14/12/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 25/04/2037
- SPC Extension Expiration:
- 25/04/2037
- Rejection date:
- Withdrawal date:
Owner
- From:
- 27/05/2024
- Name:
- ONCOPEPTIDES INNOVATION AB
- Address:
- Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)
History of Owners
- From:
- 13/12/2022
- To:
- 27/05/2024
- Name:
- Oncopeptides AB
- Address:
- Västra Trädgårdsgatan 15, 111 53 Stockholm, Sweden (SE)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 13/12/2022
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/01
- Publication date:
- 03/01/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2024/07
- Publication date:
- 03/06/2024
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/07
- Publication date:
- 04/06/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20240000244A
- Date Registered:
- 27/05/2024
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- ONCOPEPTIDES INNOVATION AB
- Address:
- Luntmakargatan 46, 111 37, Stockholm, Sweden (SE)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 30/04/2032
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 13/12/2022 | Application Form | 3 |
| 13/12/2022 | Marketing authorization | 3 |
| 13/12/2022 | Summary of the product caracteristics | 33 |
| 13/12/2022 | MA publication | 8 |
| 14/12/2022 | Outgoing Correspondence | 1 |
| 27/05/2024 | Request For Change | 17 |
| 31/05/2024 | Outgoing Correspondence | 1 |
| 14/12/2022 | Publication | 1 |
| 12/05/2025 | Publication | 1 |
| 12/05/2025 | Outgoing Correspondence | 1 |
| 12/05/2025 | Certificate | 1 |